Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3078 studies found for:    "Hepatitis A"
Show Display Options
Rank Status Study
21 Completed Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: Twinrix;   Biological: Engerix-B;   Biological: Havrix;   Biological: HBVAXPRO;   Biological: Vaqta
22 Completed Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Healive+Healive;   Biological: Healive+Havrix;   Biological: Havrix+Havrix;   Biological: Havrix+Healive
23 Recruiting This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama in 2007-2008
Condition: Hepatitis A Vaccine
Intervention: Procedure: Blood sample collection
24 Completed
Has Results
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™
25 Completed Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population
Condition: Hepatitis A
Intervention: Biological: Hepatitis A
26 Completed Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults
Condition: Hepatitis A
Interventions: Biological: Inactivated HAV vaccine;   Biological: Live attenuated HAV vaccine
27 Completed Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
Condition: Hepatitis A
Intervention: Biological: Hepatitis A
28 Completed Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™;   Biological: Engerix™-B;   Biological: HAVRIX™;   Biological: HB VAX PRO™;   Biological: Vaqta™
29 Completed Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Condition: Hepatitis A
Intervention: Other: Data collection
30 Completed Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
Conditions: Acute Hepatitis A;   Hepatitis
Intervention: Procedure: Serum sample
31 Completed
Has Results
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
Condition: Hepatitis A
Interventions: Biological: Havrix®;   Biological: M-M-R®II;   Biological: VARIVAX®
32 Withdrawn Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Conditions: Hepatitis B;   Hepatitis A
Intervention: Procedure: Blood sampling
33 Completed Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine
Conditions: Hepatitis A;   Hepatitis B
Interventions: Biological: Inactivated Hepatitis A vaccine (HAV);   Biological: Combined hepatitis A and hepatitis B vaccine (HABV)
34 Completed
Has Results
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Conditions: Hepatitis A Vaccine;   Hepatitis A
Interventions: Biological: Havrix™;   Biological: Infanrix™;   Biological: ActHIB™
35 Completed Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine
Condition: Hepatitis A
Interventions: Biological: Epaxal 0.25 mL;   Biological: Epaxal 0.5 mL;   Biological: Havrix Junior 0.5 mL
36 Completed Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Condition: Hepatitis A
Intervention: Biological: Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix
37 Completed Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients
Condition: Hepatitis B
Intervention: Biological: Engerix-B and Twinrix
38 Unknown  PCV13 + Hepatitis A Vaccine for Adults
Conditions: Measurement of Immune Response to Prevenar13;   Measurement of Immune Response to Hepatitis A
Interventions: Biological: Prevenar13;   Biological: Hepatitis A vaccine
39 Completed
Has Results
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)
Condition: Hepatitis A Virus Infection
Intervention: Biological: Hepatitis A Vaccine, Purified Inactivated (VAQTA™)
40 Completed Hepatitis C: Grading and Staging by MR
Condition: Hepatitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.